Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3565-3569

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zama, T.
Right arrow Articles by Ikeda, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zama, T.
Right arrow Articles by Ikeda, Y.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3565-3569.)
© 1997 American Heart Association, Inc.


Articles

A 192Arg Variant of the Human Paraoxonase (HUMPONA) Gene Polymorphism Is Associated With an Increased Risk for Coronary Artery Disease in the Japanese

Takeru Zama; Mitsuru Murata; Yumiko Matsubara; Koichi Kawano; Nobuo Aoki; Hideaki Yoshino; Gentaro Watanabe; Kyozo Ishikawa; ; Yasuo Ikeda

From the Department of Medicine, School of Medicine, Keio University, the Second Department of Medicine, Kyorin University (K.K., N.A., H.Y., K.I.), and Hibiya Medical Center, Sakura Bank (G.W.), Tokyo, Japan.

Correspondence to Mitsuru Murata, MD, Department of Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan. E-mail murata{at}mc.med.keio.ac.jp

Abstract Recent reports have suggested that polymorphisms in the human paraoxonase (HUMPONA) gene may be a genetic risk factor for coronary artery disease (CAD) in white populations. However, this association has not yet been confirmed in other ethnic populations. We studied 75 Japanese patients with CAD, whose coronary lesions were confirmed by angiography, and 115 Japanese control subjects with no history of CAD and a normal resting electrocardiogram. The assays for genotyping the two polymorphisms in the HUMPONA gene (192Arg/Gln and 55Leu/Met) were based on changes in restriction enzyme digestion patterns. For codon 192, the frequencies of the Arg-coding allele (B allele) in both patients and control subjects were much higher than those from published results of whites (.26 to .31), and the difference between patients (.74) and control subjects (.59) was statistically significant (P=.002). The patient group had a higher proportion of Arg/Arg (B/B) homozygotes (52.0% vs 32.2%, P=.006). For codon 55, the frequencies of the Leu-coding allele in control subjects and patients were much higher (.91 and .93, respectively) than those published results for whites, but there was no difference between Japanese control subjects and Japanese patients. When subjects with the 55Leu/Leu genotype only were analyzed, 192Arg/Arg homozygotes were still significantly more frequent in the patients than in the control subjects (55.4% vs 37.2%, P=.024), and the frequency of the 192Arg allele was also higher in patients than control subjects (P=.013). Logistic regression analysis including conventional coronary risk factors revealed that 192Arg is an independent risk factor for CAD. Thus, in the Japanese, the association of CAD with the 192Arg variant of HUMPONA (B-type enzyme) is similar to that reported for whites, although the allele frequencies for 192Arg and 55Leu are much higher in the former than the latter population.


Key Words: paraoxonase • coronary artery disease • genetics • angiography • risk factors




This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
S. Lavi, J. P. McConnell, R. Lavi, G. W. Barsness, C. S. Rihal, G. D. Novak, L. O. Lerman, and A. Lerman
Association Between the Paraoxonase-1 192Q>R Allelic Variant and Coronary Endothelial Dysfunction in Patients With Early Coronary Artery Disease
Mayo Clin. Proc., February 1, 2008; 83(2): 158 - 164.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. W. Browne, S. T. Koury, S. Marion, G. Wilding, P. Muti, and M. Trevisan
Accuracy and Biological Variation of Human Serum Paraoxonase 1 Activity and Polymorphism (Q192R) by Kinetic Enzyme Assay
Clin. Chem., February 1, 2007; 53(2): 310 - 317.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. I. Kakafika, S. Xenofontos, V. Tsimihodimos, A. P. Tambaki, E. S. Lourida, R. Kalaitzidis, M. A. Cariolou, M. Elisaf, and A. D. Tselepis
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity
J. Lipid Res., October 1, 2003; 44(10): 1919 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. P. Jarvik, T. S. Hatsukami, C. Carlson, R. J. Richter, R. Jampsa, V. H. Brophy, S. Margolin, M. Rieder, D. Nickerson, G. D. Schellenberg, et al.
Paraoxonase Activity, But Not Haplotype Utilizing the Linkage Disequilibrium Structure, Predicts Vascular Disease
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1465 - 1471.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X. Wang, Z. Fan, J. Huang, S. Su, Q. Yu, J. Zhao, R. Hui, Z. Yao, Y. Shen, B. Qiang, et al.
Extensive Association Analysis Between Polymorphisms of PON Gene Cluster With Coronary Heart Disease in Chinese Han Population
Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 328 - 334.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. P. Jarvik, N. T. Tsai, L. A. McKinstry, R. Wani, V. H. Brophy, R. J. Richter, G. D. Schellenberg, P. J. Heagerty, T. S. Hatsukami, and C. E. Furlong
Vitamin C and E Intake Is Associated With Increased Paraoxonase Activity
Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1329 - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Deakin, I. Leviev, V. Nicaud, M.-C. B. Meynet, L. Tiret, and R. W. James
Paraoxonase-1 L55M Polymorphism Is Associated with an Abnormal Oral Glucose Tolerance Test and Differentiates High Risk Coronary Disease Families
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1268 - 1273.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Markus, Z. Kapozsta, R. Ditrich, C. Wolfe, N. Ali, J. Powell, M. Mendell, and M. Cullinane
Increased Common Carotid Intima-Media Thickness in UK African Caribbeans and Its Relation to Chronic Inflammation and Vascular Candidate Gene Polymorphisms
Stroke, November 1, 2001; 32(11): 2465 - 2471.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Mackness, G. K. Davies, W. Turkie, E. Lee, D. H. Roberts, E. Hill, C. Roberts, P. N. Durrington, and M. I. Mackness
Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype?
Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1451 - 1457.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. N. Durrington, B. Mackness, and M. I. Mackness
Paraoxonase and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 473 - 480.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Senti, M. Tomas, J. Marrugat, R. Elosua, and f. t. REGICOR Investigators
Paraoxonase1-192 Polymorphism Modulates the Nonfatal Myocardial Infarction Risk Associated With Decreased HDLs
Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. P. Jarvik, L. S. Rozek, V. H. Brophy, T. S. Hatsukami, R. J. Richter, G. D. Schellenberg, and C. E. Furlong
Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1192 or PON155 Genotype
Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2441 - 2447.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Sen-Banerjee, X. Siles, and H. Campos
Tobacco Smoking Modifies Association Between Gln-Arg192 Polymorphism of Human Paraoxonase Gene and Risk of Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2120 - 2126.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. W. James, I. Leviev, and A. Righetti
Smoking Is Associated With Reduced Serum Paraoxonase Activity and Concentration in Patients With Coronary Artery Disease
Circulation, May 16, 2000; 101(19): 2252 - 2257.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Leviev and R. W. James
Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase Activities and Concentrations
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 516 - 521.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C Aubo, M Senti, J Marrugat, M Tomas, J Vila, J Sala, and R Masia
Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus
Eur. Heart J., January 1, 2000; 21(1): 33 - 38.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. C. Sorenson, C. L. Bisgaier, M. Aviram, C. Hsu, S. Billecke, and B. N. La Du
Human Serum Paraoxonase/Arylesterase's Retained Hydrophobic N-Terminal Leader Sequence Associates With HDLs by Binding Phospholipids : Apolipoprotein A-I Stabilizes Activity
Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2214 - 2225.
[Abstract] [Full Text] [PDF]